Chordoma Foundation
@chordomafdn
Improving the lives of those affected by chordoma. Leading the search for a cure.
Newsletter signup: chordoma.org/newsletter
ID: 44783529
http://www.chordoma.org 05-06-2009 01:13:04
3,3K Tweet
1,1K Followers
855 Following
We're happy to share that Pyxis Oncology's Phase 1 trial of PYX-201 (Micvotabart pelidotinaka “MICVO”) has opened to patients with sarcomas, including chordoma: clinicaltrials.gov/study/NCT05720… This opportunity came about in part from a discovery made using tumor tissue from our Biobank,